Tiffany Tang

1.6k total citations
34 papers, 586 citations indexed

About

Tiffany Tang is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Tiffany Tang has authored 34 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 17 papers in Oncology and 8 papers in Genetics. Recurrent topics in Tiffany Tang's work include Lymphoma Diagnosis and Treatment (22 papers), Viral-associated cancers and disorders (10 papers) and CNS Lymphoma Diagnosis and Treatment (8 papers). Tiffany Tang is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Viral-associated cancers and disorders (10 papers) and CNS Lymphoma Diagnosis and Treatment (8 papers). Tiffany Tang collaborates with scholars based in Singapore, South Korea and China. Tiffany Tang's co-authors include Soon Thye Lim, Young Hyeh Ko, Seok Jin Kim, Eric Tse, Won Seog Kim, Wee Joo Chng, Yok‐Lam Kwong, Harinder Gill, Siok‐Bian Ng and Florence Loong and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Tiffany Tang

31 papers receiving 578 citations

Peers

Tiffany Tang
Qun‐pei Yang China
Xi-Wen Bi China
Barbara Jezeršek Novaković Slovenia
Fiona Miall United Kingdom
C. Jonas United States
Christian W. Scholz Germany
Peter Forsyth United Kingdom
Sverker Hasselblom Sweden
Niels Smedegaard Andersen Denmark
Qun‐pei Yang China
Tiffany Tang
Citations per year, relative to Tiffany Tang Tiffany Tang (= 1×) peers Qun‐pei Yang

Countries citing papers authored by Tiffany Tang

Since Specialization
Citations

This map shows the geographic impact of Tiffany Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiffany Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiffany Tang more than expected).

Fields of papers citing papers by Tiffany Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiffany Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiffany Tang. The network helps show where Tiffany Tang may publish in the future.

Co-authorship network of co-authors of Tiffany Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Tiffany Tang. A scholar is included among the top collaborators of Tiffany Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiffany Tang. Tiffany Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lee, Wendy W. L., Jing Quan Lim, Tiffany Tang, et al.. (2024). Counterproductive effects of anti-CD38 and checkpoint inhibitor for the treatment of NK/T cell lymphoma. Frontiers in Immunology. 15. 1346178–1346178.
3.
Tan, Sze Huey, Vivianne Shih, Qingyuan Zhuang, et al.. (2020). 326P Management of diffuse large B cell lymphomas in the COVID-19 era. Annals of Oncology. 31. S1368–S1368. 1 indexed citations
4.
Huang, Dachuan, Tammy Song, Maarja‐Liisa Nairismägi, et al.. (2020). Evaluation of the PIK3 pathway in peripheral T‐cell lymphoma and NK/T‐cell lymphoma. British Journal of Haematology. 189(4). 731–744. 20 indexed citations
5.
6.
Chia, Burton Kuan Hui, Lay Poh Khoo, Chee Leong Cheng, et al.. (2018). Peripheral blood neutrophil-to-lymphocyte ratio in NK/T-cell lymphoma - prognostic significance and correlation with tumor transcriptomic profiles. Annals of Oncology. 29. ix88–ix89.
7.
Chan, Alexandre, Eileen Poon, Wei Lin Goh, et al.. (2018). Assessment of psychological distress among Asian adolescents and young adults (AYA) cancer patients using the distress thermometer: a prospective, longitudinal study. Supportive Care in Cancer. 26(9). 3257–3266. 39 indexed citations
8.
9.
Quek, R., Wen Yee Chay, Sze Huey Tan, et al.. (2017). Phase 2 clinical study of metronomic oral cyclophosphamide (MOC) in advanced sarcomas. Annals of Oncology. 28. x149–x150. 1 indexed citations
10.
Shah, Esha T., Lisa Philp, Tiffany Tang, et al.. (2016). Repositioning “old” drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion. Clinical & Experimental Metastasis. 33(4). 385–399. 18 indexed citations
11.
Tang, Tiffany, Kevin Tay, Miriam Tao, et al.. (2016). A Phase II Study of Bortezomib-GIFOX (Gemcitabine, Ifosfamide, Oxaliplatin) in Patients with Newly Diagnosed Natural-Killer/T-Cell Lymphoma. Blood. 128(22). 5353–5353. 10 indexed citations
12.
Wong, Wendy, et al.. (2016). Clinical and molecular characteristics of East Asian patients with von Hippel–Lindau syndrome. Chinese Journal of Cancer. 35(1). 79–79. 5 indexed citations
13.
Tang, Tiffany, Zhengming Chen, Lay Poh Khoo, et al.. (2015). Role of Surveillance Imaging in Patients With Peripheral T-Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 16(3). 117–121. 8 indexed citations
14.
Tan, Hui Shan, Huihua Li, Chee‐Keong Toh, et al.. (2014). Efficacy and Safety of an Attenuated-Dose Sunitinib Regimen in Metastatic Renal Cell Carcinoma: Results From a Prospective Registry in Singapore. Clinical Genitourinary Cancer. 13(4). e285–e295. 22 indexed citations
15.
Tse, Eric, Thomas S. Y. Chan, W-J Chng, et al.. (2014). Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group. Bone Marrow Transplantation. 49(7). 902–906. 64 indexed citations
16.
Ahn, Hee Kyung, Seok Jin Kim, Young Hyeh Ko, et al.. (2012). Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma. Investigational New Drugs. 31(2). 469–472. 45 indexed citations
17.
Tan, Leonard, et al.. (2012). Does the proliferation fraction help identify mature B cell lymphomas with double‐ and triple‐hit translocations?. Histopathology. 61(6). 1214–1218. 27 indexed citations
18.
Tse, Eric, Harinder Gill, Florence Loong, et al.. (2012). Type II enteropathy‐associated T‐cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group. American Journal of Hematology. 87(7). 663–668. 115 indexed citations
19.
Tang, Tiffany, Wen Yee Chay, Christopher Goh, et al.. (2011). Nasal metastases from renal cell carcinoma are associated with Memorial Sloan-Kettering Cancer Center poor-prognosis classification. Chinese Journal of Cancer. 30(2). 144–148. 9 indexed citations
20.
Tan, Min‐Han, Huihua Li, Kee Seng Chia, et al.. (2011). The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinoma. Cancer. 117(23). 5314–5324. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qun‐pei Yang Breakdown of academic impact, for papers by Xi-Wen Bi Breakdown of academic impact, for papers by Barbara Jezeršek Novaković Breakdown of academic impact, for papers by Fiona Miall Breakdown of academic impact, for papers by C. Jonas Breakdown of academic impact, for papers by Christian W. Scholz Breakdown of academic impact, for papers by Peter Forsyth Breakdown of academic impact, for papers by Sverker Hasselblom Breakdown of academic impact, for papers by Niels Smedegaard Andersen
Rankless by CCL
2026